(R)-1-((4-chlorophenyl)(phenyl)methyl)-4-(3-chloropropyl)piperazine | 942132-43-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (R)-1-((4-chlorophenyl)(phenyl)methyl)-4-(3-chloropropyl)piperazine
• CAS: 942132-43-6
• 化学式: C₂₀H₂₄Cl₂N₂
• 分子量: 363.33
• InChiKey: NXKIKVTUKCLNRP-HXUWFJFHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.68
• 重原子数：
  24.0
• 可旋转键数：
  6.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  6.48
• 氢给体数：
  0.0
• 氢受体数：
  2.0

反应信息

• 作为反应物：
  描述：

  (R)-1-((4-chlorophenyl)(phenyl)methyl)-4-(3-chloropropyl)piperazine 、 磺胺氯哒嗪 在 potassium carbonate 、 三乙胺 作用下， 以 丙酮 为溶剂， 以43%的产率得到4-amino-N-[3-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]propyl]-N-(6-chloropyridazin-3-yl)benzenesulfonamide
  参考文献：
  名称：

  Design, synthesis, and anti-allergic activities of novel (R)(-)-1-[(4-chlorophenyl)phenyl methyl]piperazine derivatives

  摘要：

  A series of novel (R)(-)-1-[(4-chlorophenyl)phenylmethyl]piperazine derivatives were designed, synthesized, and tested for in vivo anti-allergic activities. Most of these derivatives exhibited significant effects on both allergic asthma and allergic itching. Three of the 19 piperazine derivatives (namely, 3d, 3i, and 3r) have stronger potency against allergic asthma than levocetirizine, the positive control drug. Meanwhile, in the test of allergic itching, five of the 19 compounds (namely, 3b, 3g, 3k, 3o, and 3s) have more potent activities than levocetirizine.

  DOI：

  10.1007/s00044-010-9512-1
• 作为产物：
  描述：

  1-溴-3-氯丙烷 、 (-)-1-[(4-氯苯基)苯甲基]哌嗪 在 三乙胺 作用下， 以 甲苯 为溶剂， 以70%的产率得到(R)-1-((4-chlorophenyl)(phenyl)methyl)-4-(3-chloropropyl)piperazine
  参考文献：
  名称：

  Design, synthesis, and anti-allergic activities of novel (R)(-)-1-[(4-chlorophenyl)phenyl methyl]piperazine derivatives

  摘要：

  A series of novel (R)(-)-1-[(4-chlorophenyl)phenylmethyl]piperazine derivatives were designed, synthesized, and tested for in vivo anti-allergic activities. Most of these derivatives exhibited significant effects on both allergic asthma and allergic itching. Three of the 19 piperazine derivatives (namely, 3d, 3i, and 3r) have stronger potency against allergic asthma than levocetirizine, the positive control drug. Meanwhile, in the test of allergic itching, five of the 19 compounds (namely, 3b, 3g, 3k, 3o, and 3s) have more potent activities than levocetirizine.

  DOI：

  10.1007/s00044-010-9512-1